IP Library Granted Patent US 9,656,020
Granted Patent B2
US 9,656,020 · App. 13/377,358 · Granted May 23, 2017

Glucagon pump controller

Inventors: Pantelis Georgiou (Wembley Middlesex, GB); Kok Thay Lim (Kuala Lumpur, MY); Christofer Toumazou (London, GB)
Assignee: IMPERIAL INNOVATIONS LIMITED
A61M5/1723G06F19/3468A61M2005/14208
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,656,020
App. No.
13/377,358
Granted
May 23, 2017
Kind
B2
Abstract

According to a first aspect of the present invention there is provided a controller for controlling a glucagon pump. The controller comprises an input 8 for receiving an input signal indicative of a measured blood glucose concentration, an output 9 for providing a pulsed glucagon pump drive signal, each pulse being arranged to cause a glucagon pump to deliver a volume of glucagon, and a processing unit 10 for setting the pulse frequency of the pump drive signal in dependence upon the input signal, such that when the input signal indicates that the measured blood glucose concentration is above a threshold concentration the pulse frequency is zero and when the input signal indicates that the measured blood glucose concentration is below the threshold concentration the pulse frequency is increased as the measured blood glucose concentration decreases.

Claims (17)

1. A controller for controlling a glucagon pump, the controller comprising:

an input arranged to receive an input signal indicative of a measured blood glucose concentration;

an output arranged to provide a pulsed glucagon pump drive signal, each pulse being arranged to cause a glucagon pump to deliver a volume of glucagon; and

a processing unit arranged to set a pulse frequency of the pump drive signal in dependence upon the input signal, such that when the input signal indicates that the measured blood glucose concentration is above a threshold concentration the pulse frequency is zero and when the input signal indicates that the measured blood glucose concentration is below the threshold concentration the pulse frequency is increased as the measured blood glucose concentration decreases, wherein the processing unit comprises a CMOS based circuit arranged to implement an integrate and fire model to simulate the electrical response of a pancreatic alpha cell to blood glucose concentration, the CMOS based circuit comprising metal-oxide-semiconductor field-effect transistors (MOSFETs),

wherein the CMOS based circuit is conductively coupled to said input, said input being conductively coupled to an output of a glucose sensor and arranged to receive an output current from the glucose sensor, and further arranged to generate action potentials approximating action potentials of alpha cells and wherein said action potentials determine said pulsed glucagon pump drive signal.

2. The controller as claimed in claim 1 , wherein the processing unit is arranged to convert a simulated electrical response of a pancreatic alpha cell to blood glucose concentration into the pulsed glucagon pump drive signal.

3. A system for controlling blood glucose concentration, the system comprising:

a glucagon pump controller according to claim 1 ; and

a glucagon pump.

4. The system as claimed in claim 3 , and further comprising:

an insulin pump controller; and

an insulin pump.

5. The system as claimed in claim 3 , and further comprising an adjustment unit for accepting input of patient specific information and for using the patient specific information to modify the volume of glucagon delivered by the glucagon pump in response to each pulse of the pump drive signal.

6. A method of operating a controller for controlling a glucagon pump, the method comprising:

receiving an input signal indicative of a measured blood glucose concentration;

processing the input signal to generate a pulsed glucagon pump drive signal, each pulse being arranged to cause a glucagon pump to deliver a volume of glucagon, setting the pulse frequency of the pump drive signal in dependence upon the input signal, such that when the input signal indicates that the measured blood glucose concentration is above a threshold concentration the pulse frequency is zero and when the input signal indicates that the measured blood glucose concentration is below the threshold concentration the pulse frequency is increased as the measured blood glucose concentration decreases, wherein the pulsed glucagon pump drive signal is generated by a processing unit comprising a CMOS based circuit arranged to implement an integrate and fire model to simulate the electrical response of a pancreatic alpha cell to blood glucose concentration, the CMOS based circuit comprising metal-oxide-semiconductor field-effect transistors (MOSFETs) and wherein the CMOS based circuit generates action potentials approximating action potentials of alpha cells and wherein said action potentials determine said pulsed glucagon pump drive signal; and

outputting the pulsed glucagon pump drive signal.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2020
From: IMPERIAL INNOVATIONS LIMITED
To: IMPERIAL WHITE CITY INCUBATOR LIMITED
Reel/Frame 054184/0242 →
CHANGE OF NAME Recorded Oct 27, 2020
From: IMPERIAL WHITE CITY INCUBATOR LIMITED
To: IMPERIAL COLLEGE INNOVATIONS LIMITED
Reel/Frame 054184/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2012
From: GEORGIOU, PANTELIS; LIM, KOK THAY; TOUMAZOU, CHRISTOFER
To: IMPERIAL INNOVATIONS LIMITED
Reel/Frame 028311/0062 →
Priority Claims (1)
GB 0909948.2 · Jun 10, 2009 · national
Continuity (1)
Related Publication 20120232519A1 · Sep 13, 2012